EpimAb Biotherapeutics Appoints Jerry Su, Ph.D. as Chief Technology Officer

EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced the appointment of Jerry Su, Ph.D. as the Chief Technology Officer of EpimAb. Dr. Su …
( read original story …)